×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Incathlab member and receive full access to its content!
You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.
Registration Login
Registration Login
Clinical Data
- Patient: Male, 56 years old
-
Inferior myocardial infarction 7/97 (thrombolysis)
-
7/97 PCI of RCA with BMS
-
2013 CTO PCI of the RCA with 4 DES (Xience) for angina
-
Asymptomatic in the last 4 years
-
No concomitant diseases known
-
CVRF: former smoker (80py), dyslipidemia
-
Since several months angina pectoris CCS II
-
Echo: LVEF 65%, normal regional function
-
Treadmill test: symptomatic, no ST changes
-
Renal function: eGFR =89 ml/min/1.73m2
-
CAG 14.7.17: LAD without stenosis, CX without stenosis, in-stent reocclusion of the RCA
-
J-CTO score: 1
Shooting date : 2017-09-13
Last update : 2017-10-31
Last update : 2017-10-31
OptiRAY® / Guerbet
Optiray® contrast agent is lower osmolar, lower viscosity and nonionic.
Cruiser / Teleflex (BIOTRONIK Vascular Intervenion)
Coronary Guide Wire Indicated for PTCA applications
SeQuent® Please NEO / B. Braun
Next generation coronary Drug Coated Balloon to treat vascular stenosis
Suggestions
Tuesday, February 3rd 2026 from 06pm to 07pm (GMT+1)
Honolulu : Tuesday, February 3rd 2026 from 07am to 08am (GMT+1)
San Francisco : Tuesday, February 3rd 2026 from 09am to 10am (GMT+1)
New York : Tuesday, February 3rd 2026 from 12pm to 01pm (GMT+1)
Buenos Aires : Tuesday, February 3rd 2026 from 02pm to 03pm (GMT+1)
London / Dublin : Tuesday, February 3rd 2026 from 05pm to 06pm (GMT+1)
Paris / Berlin : Tuesday, February 3rd 2026 from 06pm to 07pm (GMT+1)
Istanbul : Tuesday, February 3rd 2026 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Tuesday, February 3rd 2026 from 09pm to 10pm (GMT+1)
Bangkok : Wednesday, February 4th 2026 from 12am to 01am (GMT+1)
Shanghai : Wednesday, February 4th 2026 from 01am to 02am (GMT+1)
Tokyo : Wednesday, February 4th 2026 from 02am to 03am (GMT+1)
Sydney : Wednesday, February 4th 2026 from 03am to 04am (GMT+1)
Wellington : Wednesday, February 4th 2026 from 05am to 06am (GMT+1)
San Francisco : Tuesday, February 3rd 2026 from 09am to 10am (GMT+1)
New York : Tuesday, February 3rd 2026 from 12pm to 01pm (GMT+1)
Buenos Aires : Tuesday, February 3rd 2026 from 02pm to 03pm (GMT+1)
London / Dublin : Tuesday, February 3rd 2026 from 05pm to 06pm (GMT+1)
Paris / Berlin : Tuesday, February 3rd 2026 from 06pm to 07pm (GMT+1)
Istanbul : Tuesday, February 3rd 2026 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Tuesday, February 3rd 2026 from 09pm to 10pm (GMT+1)
Bangkok : Wednesday, February 4th 2026 from 12am to 01am (GMT+1)
Shanghai : Wednesday, February 4th 2026 from 01am to 02am (GMT+1)
Tokyo : Wednesday, February 4th 2026 from 02am to 03am (GMT+1)
Sydney : Wednesday, February 4th 2026 from 03am to 04am (GMT+1)
Wellington : Wednesday, February 4th 2026 from 05am to 06am (GMT+1)
Novel HC-IVL technique to maximize calcium fractures to improve vessels compliance
Share
Thursday, September 14th 2017 from 01pm to 02:30pm (GMT+2)
Honolulu : Thursday, September 14th 2017 from 02am to 03:30am (GMT+2)
San Francisco : Thursday, September 14th 2017 from 05am to 06:30am (GMT+2)
New York : Thursday, September 14th 2017 from 08am to 09:30am (GMT+2)
Buenos Aires : Thursday, September 14th 2017 from 09am to 10:30am (GMT+2)
Reykjavik : Thursday, September 14th 2017 from 12pm to 01:30pm (GMT+2)
London / Dublin : Thursday, September 14th 2017 from 01pm to 02:30pm (GMT+2)
Paris / Berlin : Thursday, September 14th 2017 from 02pm to 03:30pm (GMT+2)
Istanbul : Thursday, September 14th 2017 from 03pm to 04:30pm (GMT+2)
Moscou / Dubaï : Thursday, September 14th 2017 from 04pm to 05:30pm (GMT+2)
Bangkok : Thursday, September 14th 2017 from 07pm to 08:30pm (GMT+2)
Shanghai : Thursday, September 14th 2017 from 08pm to 09:30pm (GMT+2)
Tokyo : Thursday, September 14th 2017 from 09pm to 10:30pm (GMT+2)
Sydney : Thursday, September 14th 2017 from 11pm to 12:30am (GMT+2)
Wellington : Friday, September 15th 2017 from 01am to 02:30am (GMT+2)
San Francisco : Thursday, September 14th 2017 from 05am to 06:30am (GMT+2)
New York : Thursday, September 14th 2017 from 08am to 09:30am (GMT+2)
Buenos Aires : Thursday, September 14th 2017 from 09am to 10:30am (GMT+2)
Reykjavik : Thursday, September 14th 2017 from 12pm to 01:30pm (GMT+2)
London / Dublin : Thursday, September 14th 2017 from 01pm to 02:30pm (GMT+2)
Paris / Berlin : Thursday, September 14th 2017 from 02pm to 03:30pm (GMT+2)
Istanbul : Thursday, September 14th 2017 from 03pm to 04:30pm (GMT+2)
Moscou / Dubaï : Thursday, September 14th 2017 from 04pm to 05:30pm (GMT+2)
Bangkok : Thursday, September 14th 2017 from 07pm to 08:30pm (GMT+2)
Shanghai : Thursday, September 14th 2017 from 08pm to 09:30pm (GMT+2)
Tokyo : Thursday, September 14th 2017 from 09pm to 10:30pm (GMT+2)
Sydney : Thursday, September 14th 2017 from 11pm to 12:30am (GMT+2)
Wellington : Friday, September 15th 2017 from 01am to 02:30am (GMT+2)
How should I treat complex anatomic lesions and manage complications?
Interactive discussion with your experts - Rotablator & CTO
Share
